# Intercure Ltd. (INCR)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Price:** $0.87 (+2.47%)

> Intercure Ltd. is a leading pharmaceutical company focused on the development, production, and distribution of cannabis-based products. It stands at the forefront of the medical cannabis industry, leveraging advanced cultivation techniques and proprietary R&D to provide high-quality treatments for a range of medical conditions. Intercure's extensive portfolio includes both therapeutic and wellness products designed to meet the needs of patients and healthcare providers. The company is engaged in several strategic partnerships and collaborations with global leaders in the pharmaceutical and wellness sectors, enhancing its market reach and innovation capabilities. Intercure's operations and distribution networks span multiple countries, positioning it as a key player in the rapidly evolving cannabis market. Through its commitment to rigorous scientific research and regulatory compliance, Intercure is instrumental in advancing the acceptance and integration of medical cannabis into mainstream healthcare solutions. Its active participation in clinical studies and contribution to cannabinoid pharmacology underscores its significant role in the field, supporting informed decisions and elevating health outcomes.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/INCR)